This announcement is a separate document:
自愿披露关于西达本胺联合R-CHOP治疗弥漫大B细胞淋巴瘤适应症获批上市的公告
Voluntary disclosure announcement on approval for marketing of sidabendamide combined with R-CHOP for the treatment of diffuse large B-cell lymphoma
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.